No abstract available
Publication types
-
Comment
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / chemistry
-
Doxorubicin / adverse effects*
-
Doxorubicin / chemistry
-
Drug Carriers
-
Extravasation of Diagnostic and Therapeutic Materials / etiology*
-
Extravasation of Diagnostic and Therapeutic Materials / pathology
-
Humans
-
Inflammation
-
Infusions, Intravenous
-
Liposomes
-
Necrosis
Substances
-
Antineoplastic Agents
-
Drug Carriers
-
Liposomes
-
Doxorubicin